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We thank Dr. Jaster for reading our articles with interest 
and sharing his thoughts on the potential impacts of 
untreated obstructive sleep apnoea (OSA) and continuous 
positive airway pressure (CPAP) effects on medullary brain 
nuclei. There are three topics we would like to address: (I) 
the hypothesis of an association between OSA and ischemic 
pathology of medullary brain nuclei and a potential 
exacerbation by CPAP, (II) the different roles of pCO2 in 
OSA and central sleep apnoea (CSA), and (III) the effects of 
a short-term CPAP withdrawal on the brain and the heart.
The view’s expressed by Dr. Jaster are interesting 
and challenging hypotheses, but so far not underlined 
by convincing scientific evidence. We couldn’t find any 
evidence for an independent association of ischaemic lesions 
of the solitary tract nuclei and OSA in the cited references 
of the author, which are letters and comments and not 
original research data. The main statement by the author 
was that untreated sleep apnoea results in medullary brain 
ischemia, which may be exacerbated by both CPAP and 
its withdrawal as a consequence of CO2-mediated cerebral 
vasoconstriction and vasodilation.
Advisement 1: autoregulation of ventilation is impaired 
in case of medullary pathology (e.g., stroke), and this 
predisposes to both sleep-disordered breathing and 
breathing disturbances during wakefulness. However, 
when thinking of a cause-effect-relationship, there is 
no convincing evidence that OSA results in ischemia-
induced changes of medullary nuclei due to perfusion or 
oxygenation impairment of the medulla. In view of the 
findings of a recent CPAP withdrawal trial demonstrating 
severe nocturnal cerebral hypoxemia in some patients with 
severe untreated OSA (1), the role of nocturnal medullary 
tissue hypoxia might be an interesting target to study to 
better understand autonomic instability/derangements and 
respiratory and cardiac control in OSA.
Advisement 2: the SAVE trial and the SERVE-HF 
trial are very important randomised controlled trials. 
The SAVE trial showed that CPAP had no effect on 
secondary prevention in patients with OSA and cardio- 
and cerebrovascular disease, and the SERVE-HF trial 
showed that adaptive servo-ventilation led to increased 
cardiovascular mortality in patients with CSA/Cheyne-
Stokes Breathing in heart failure. These trials leave 
many questions unanswered and many have speculated 
on potential mechanisms that might explain these rather 
unexpected findings—indeed the hypothesis of Dr. Jaster 
could be further elucidated in patients with CSA on assisted 
servo-ventilation. However, the two trials included two 
pathophysiological distinct forms of sleep disordered 
breathing—OSA and CSA. Despite the known effects of 
PaCO2 changes on cerebral vascular tone, the effects of 
OSA on cerebral autoregulation seem to be more complex 
and not only affected by PaCO2. We agree that the 
potential effects of positive airway pressure and especially 
invasive mechanical ventilation on cerebral perfusion as 
consequences of changes in PaCO2 and haemodynamic 
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have to be kept in mind in specific patient groups. Studying 
patients with treatment-emergent CSA while being treated 
with CPAP for OSA might give further insight into the 
topics raised by Dr. Jaster.
Advisement 3: OSA is usually undiagnosed and untreated 
for several years and CPAP is often not used over the 
whole night. It is unlikely that changes to the mentioned 
nuclei tract will occur within two weeks of untreated OSA 
or that CPAP withdrawal causes a reperfusion injury to 
the medulla oblongata. It is also unlikely that medullary 
changes explain any of the consequences found in response 
to OSA recurrence in short-term CPAP withdrawal. Several 
randomised controlled trials have demonstrated the safety 
of a short-term CPAP withdrawal in both populations 
with and without cardio- and cerebrovascular disease (2,3). 
We found that CPAP withdrawal results in a pronounced 
increase in blood pressure and other consequences of 
untreated OSA, which include both persistent and cycling 
nocturnal cerebral tissue oxygenation. However, we also 
have observed that CPAP withdrawal neither affects 
myocardial (1) nor cerebral endothelial function during 
wakefulness.
Overall, the hypotheses expressed here are of interest 
and changes in the medulla oblongata could be addressed in 
future physiological and clinical trials in OSA.
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